SEC Form 4 · accession 0001209191-19-004819
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yao Wenqing
Officer — EVP, Head of Discovery Chem
Period of report
Jan 17, 2019
Accepted (ET)
Jan 22, 2019 · 6:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 17, 2019 | M | 15,354 | $17.79 | A | 49,763 | D | |
| Common StockF1,F2,F3,F4 | Jan 17, 2019 | S | 15,354 | $77.61 | D | 34,409 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F5 | $17.79 | Jan 17, 2019 | M | 15,354 | D | — | Jan 18, 2019 | Common Stock | 15,354 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- F2Represents weighted average sale price. Actual sale prices ranged from $76.43 to $78.56.
- F3Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- F4This includes an aggregate of 5,416 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F5Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.